Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

P16 UV mutations in human skin epithelial tumors

Abstract

The p16 gene expresses two alternative transcripts (p16α and p16β) involved in tumor suppression via the retinoblastoma (Rb) or p53 pathways. Disruption of these pathways can occur through inactivation of p16 or p53, or activating mutations of cyclin dependant kinase 4 gene (Cdk4). We searched for p16, Cdk4 and p53 gene mutations in 20 squamous cell carcinomas (SSCs), 1 actinic keratosis (AK), and 28 basal cell carcinomas (BCCs), using PCR-SSCP. A deletion and methylation analysis of p16 was also performed. Six different mutations (12%) were detected in exon 2 of p16 (common to p16α and p16β), in five out of 21 squamous lesions (24%) (one AK and four SCCs) and one out of 28 BCCs (3.5%). These included four (66%) ultraviolet (UV)-type mutations (two tandems CC : GG to TT : AA transitions and two C : G to T : A transitions at dipyrimidic site) and two transversions. P53 mutations were present in 18 samples (37%), mostly of UV type. Of these, only two (one BCC and one AK) harboured simultaneously mutations of p16, but with no consequence on p16β transcript. Our data demonstrate for the first time the presence of p16 UV induced mutations in non melanoma skin cancer, particularly in the most aggressive SCC type, and support that p16 and p53 are involved in two independent pathways in skin carcinogenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Basset-Seguin N, Moles JP, Mils V, Dereure O and Guilhou JJ. . 1994 J. Invest. Dermatol. 103: 102S–106S.

  • Beroud C and Soussi T. . 1998 Nucleic Acids Res. 26: 200–204.

  • Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin A and Ponten J. . 1991 Proc. Natl. Acad. Sci. USA 88: 10124–10128.

  • Chang TG, Wang J, Chen LW, Hsu CY, Chang HW, Chen JS and Cho CL. . 1997 Biochem. Biophys. Res. Commun. 230: 85–88.

  • Chaubert P, Shaw P and Pillet N. . 1996 Mol. Cell. Probes 10: 467–468.

  • Coleman KG, Wautlet BS, Morrissey D, Mulheron J, Sedman SA, Brinkley P, Price S and Webster KR. . 1997 J. Biol. Chem. 272: 18869–18874.

  • Enders GH, Koh J, Missero C, Rustgi AK and Harlow E. . 1996 Oncogene 12: 1239–1245.

  • Gailani MR, Stahle-Backdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, Pressman C, Unden AB, Dean M, Brash DE, Bale AE and Toftgard R. . 1996 Nat. Genet. 14: 78–81.

  • Gruis NA, Weaver-Feldhaus J, Liu Q, Frye C, Eeles R, Orlow I, Lacombe L, Ponce-Castaneda V, Lianes P, Latres E, et al., 1995 Am. J. Pathol. 146: 1199–1206.

  • Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M, Harris CC and Montesano R. . 1998 Nucleic Acids Res. 26: 205–213.

  • Healy E, Sikkink S and Rees JL. . 1996 J. Invest. Dermatol. 107: 318–321.

  • Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark Jr WH, Tucker MA and Dracopoli NC. . 1994 Nat. Genet. 1: 15–21.

  • Jares P, Fernandez PL, Nadal A, Cazorla M, Hernandez L, Pinyol M, Hernandez S, Traserra J, Cardesa A and Campo E. . 1997 Oncogene 15: 1445–1453.

  • Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE and Skolnick MH. . 1994 Science 264: 436–440.

  • Kubo Y, Urano Y, Matsumoto K, Ahsan K and Arase S. . 1997 Biochem. Biophys. Res. Commun. 232: 38–41.

  • Lilischkis R, Sarcevic B, Kennedy C, Warlters A and Sutherland RL. . 1996 Int. J. Cancer 66: 249–254.

  • Linardopoulos S, Street AJ, Quelle DE, Parry D, Peters G, Sherr CJ and Balmain A. . 1995 Cancer Res. 55: 5168–5172.

  • Liu Q, Neuhausen S, McClure M, Frye C, Weaver-Feldhaus J, Gruis NA, Eddington K, Allalunis-Turner MJ, Skolnick MH, Fujimura FK, et al. 1995 Oncogene 10: 1061–1067.

  • Lo KW, Huang DP and Lau KM. . 1995 Cancer Res. 55: 2039–2043.

  • Maestro R and Boiocchi M. . 1995 Science 267: 15–16.

  • Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D. . 1995 Nat. Med. 1: 686–692.

  • Molès JP, Moyret C, Guillot B, Jeanteur P, Guilhou JJ, Theillet C and Basset-Seguin N. . 1993 Oncogene 8: 583–588.

  • Muzeau F, Flejou FJ, Thomas G and Hamelin R. . 1997 Int. J. Cancer 72: 27–30.

  • Nataraj AJ, Trent 2nd, JC and Ananthaswamy HN. . 1995 Photochem. Photobiol. 62: 218–230.

  • Nishigori C, Wang S, Miyakoshi J, Sato M, Tsukada T, Yagi T, Imamura S and Takebe H. . 1994 Proc. Natl. Acad. Sci. USA 91: 7189–7193.

  • Oro AE, Higgins KM, Hu Z, Bonifas JM, Epstein Jr, EH and Scott MP. . 1997 Science 276: 817–821.

  • Pollock PM, Yu F, Qiu L, Parsons PG and Hayward NK. . 1995 Oncogene 11: 663–668.

  • Pollock PM, Pearson JV and Hayward NK. . 1996 Genes Chrom. Cancer 15: 77–88.

  • Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C and DePinho RA. . 1998 Cell 92: 713–723.

  • Quelle DE, Cheng M, Ashmun RA and Sherr CJ. . 1997 Proc. Natl. Acad. Sci. USA 94: 669–673.

  • Quelle DE, Zindy F, Ashmun RA and Sherr CJ. . 1995 Cell 83: 993–1000.

  • Quinn AG, Sikkink S and Rees JL. . 1994a Cancer Res. 54: 4756–4759.

  • Quinn AG, Campbell C, Healy E and Rees JL. . 1994b J. Invest. Dermatol. 102: 300–303.

  • Rehman I, Takata M, Wu YY and Rees JL. . 1996 Oncogene 12: 2483–2490.

  • Robles AI, Rodriguez-Puebla ML, Glick AB, Trempus C, Hansen L, Sicinski P, Tennant RW, Weinberg RA, Yuspa SH and Conti CJ. . 1998 Genes Dev. 12: 2469–2474.

  • Serrano M, Hannon GJ and Beach D. . 1993 Nature 366: 704–707.

  • Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D and DePinho RA. . 1996 Cell 85: 27–37.

  • Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, Stoppa-Lyonnet D, Benard J and Bressac-de Paillerets B. . 1998 Hum. Mol. Genet. 7: 209–216.

  • Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH and Peters G. . 1998 EMBO J. 17: 5001–5014.

  • Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G and Kamb A. . 1995 Cancer Res. 55: 2988–2994.

  • Ueki K, Rubio MP, Ramesh V, Correa KM, Rutter JL, von Deimling A, Buckler AJ, Gusella JF and Louis DN. . 1994 Hum. Mol. Genet. 3: 1841–1845.

  • Wang XQ, Gabrielli BG, Milligan A, Dickinson JL, Antalis TM and Ellem KA. . 1996 Cancer Res. 56: 2510–2514.

  • Whelan AJ, Bartsch D and Goodfellow PJ. . 1995 N. Eng. J. Med. 333: 975–977.

  • Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, Bonifas JM, Lam CW, Hynes M, Goddard A, Rosenthal A, Epstein Jr, EH and de Sauvage FJ. . 1998 Nature 391: 90–92.

  • Yang R, Serrano M, Slater J, Leung E and Koeffler HP. . 1996 Biochem. Biophys. Res. Commun. 218: 254–259.

  • Yarbrough WG, Aprelikova O, Pei H, Olshan AF and Liu ET. . 1996 J. Natl. Cancer Inst. 88: 1489–1491.

  • Zhang Y, Xiong Y and Yarbrough WG. . 1998 Cell 92: 725–734.

  • Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward N and Dracopoli NC. . 1996 Nat. Genet. 12: 97–99.

Download references

Acknowledgements

This work was supported by grants from AP-HP, CERIES and GEFLUC. Nadem Soufir is a predoctoral fellowship of the Ligue Nationale contre le Cancer.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Soufir, N., Molès, J., Vilmer, C. et al. P16 UV mutations in human skin epithelial tumors. Oncogene 18, 5477–5481 (1999). https://doi.org/10.1038/sj.onc.1202915

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202915

Keywords

This article is cited by

Search

Quick links